Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, in New York City, U.S., December ...

The US Food and Drug Administration has just approved the use of lisdexamfetamine dimesylate for the treatment of binge eating disorder. Licensed under the brand name Vyvanse, lisdexamfetamine is the ...

New research out of the University of Pennsylvania has helped identify how major weight-loss drugs suppress so-called "food noise" in the brain. "Developing new ways to treat these patients is of the ...

The new incretin-based medications are a class of antidiabetic drugs that stabilize blood glucose by stimulating insulin secretion and suppressing glucagon production in the body in response to energy ...

The New York Times describes the new movement uniting the obese and people with eating disorders. The issue that unites them is binge eating—an addictive behavior. Not all obese people are binge ...

(Reuters) -Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 weight-loss drug appeared to temporarily suppress food-craving ...